• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Metalloid salts

Recent Advances in Nickel Diarsenide (12068-61-0) Research: Implications for Chemical Biomedicine

Nickel diarsenide (CAS: 12068-61-0) is an intermetallic compound that has garnered increasing attention in the field of chemical biomedicine due to its unique physicochemical properties and potential applications. Recent studies have explored its structural characteristics, electronic properties, and possible biomedical uses, making it a subject of significant scientific interest. This research brief synthesizes the latest findings on nickel diarsenide, focusing on its synthesis, characterization, and emerging applications in biomedicine.

One of the key advancements in nickel diarsenide research involves its synthesis and structural analysis. A 2023 study published in the Journal of Materials Chemistry demonstrated a novel hydrothermal synthesis method for producing high-purity nickel diarsenide nanoparticles. The researchers highlighted the compound's layered structure, which exhibits anisotropic electronic properties, making it a promising candidate for electronic and optoelectronic devices. Furthermore, the study revealed that the compound's stability under physiological conditions could be leveraged for biomedical applications.

In the realm of biomedicine, nickel diarsenide has shown potential as a contrast agent for imaging technologies. A recent preprint on bioRxiv reported that nickel diarsenide nanoparticles exhibit strong X-ray attenuation properties, comparable to traditional iodine-based contrast agents. This finding opens new avenues for developing safer and more efficient contrast materials for computed tomography (CT) scans. Additionally, preliminary in vitro studies indicated low cytotoxicity, suggesting good biocompatibility for medical use.

Another groundbreaking study, published in Advanced Functional Materials in early 2024, investigated the catalytic properties of nickel diarsenide in drug synthesis. The researchers found that the compound could serve as an efficient catalyst for the synthesis of certain antineoplastic agents, reducing reaction times and improving yields. This discovery has significant implications for pharmaceutical manufacturing, potentially streamlining the production of complex drug molecules.

Despite these promising developments, challenges remain in the widespread adoption of nickel diarsenide in biomedical applications. A critical review in Chemical Society Reviews emphasized the need for further toxicological studies to fully assess the long-term safety of nickel diarsenide nanoparticles in vivo. Additionally, scalable synthesis methods must be developed to meet potential industrial demands. Addressing these challenges will be crucial for translating laboratory findings into clinical and industrial applications.

In conclusion, nickel diarsenide (12068-61-0) represents a fascinating material at the intersection of chemistry and biomedicine. Recent research has uncovered its potential in imaging, drug synthesis, and electronic applications, while also highlighting areas requiring further investigation. As studies continue to elucidate its properties and applications, nickel diarsenide may emerge as a valuable tool in advancing both chemical and biomedical sciences.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)